IHH Healthcare Boosts India Tech Investments

IHH Healthcare, a major healthcare provider headquartered in Malaysia, is set to substantially increase its technology investments in India. These investments will be channeled through its subsidiary, Fortis Healthcare, which operates a network of 36 facilities with approximately 6,100 beds.

Fortis will be the central platform for IHH's strategic growth in India, focusing on innovations in artificial intelligence, precision medicine, and advanced oncology. The company also aims to expand its bed capacity to 10,000 by 2030, ensuring state-of-the-art equipment for patient treatment.

Key initiatives include leveraging technologies like MR-LINAC for cancer treatment and exploring proton beam therapy. Precision medicine, particularly through Fortis' diagnostics arm Agilus, will focus on genomics for personalized oncology. A unified data platform is being rolled out to support AI applications across IHH's network, with a strong emphasis on data privacy and compliance.

IHH is also actively seeking investments in healthtech startups through its Catalyst Health Innovation Challenge. This initiative provides Indian startups access to IHH's global healthcare ecosystem for testing and scaling their solutions, fostering innovation within Fortis and potentially across IHH's international operations.